PROPOSED CHANGES TO HSR RULES FOR PHARMACEUTICAL COMPANIES* Today the Federal Trade Commission (FTC) announced proposed changes to the Hart-Scott-Rodino (HSR) premerger notification rules that will impact the types of transactions for which pharmaceutical companies will be required to file HSR notifications with the Department of Justice and FTC. The proposed
The US FTC announces proposed changes to the Hart-Scott-Rodino pre-merger notification rules for pharmaceutical companies
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.